Pretreatment with ablative fractional carbon dioxide laser improves treatment efficacy in a synergistic PDT protocol for actinic keratoses on the head

•S-PDT with AFXL pretreatment is safe and effective for AKs on the head.•Compared to s-PDT without pretreatment, AFXL showed significantly superior efficacy.•S-PDT and AFXL procedure worked out to be almost painless. A recently proposed synergistic photodynamic therapy protocol (s-PDT) combining adv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Photodiagnosis and photodynamic therapy 2021-06, Vol.34, p.102249, Article 102249
Hauptverfasser: Falkenberg, C., Schmitz, L., Dicke, K., Dervenis, V., Szeimies, R.M., Dirschka, T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•S-PDT with AFXL pretreatment is safe and effective for AKs on the head.•Compared to s-PDT without pretreatment, AFXL showed significantly superior efficacy.•S-PDT and AFXL procedure worked out to be almost painless. A recently proposed synergistic photodynamic therapy protocol (s-PDT) combining advantages of both conventional- and daylight-PDT proved to be an effective and almost painless treatment for patients with actinic keratoses (AKs). This study investigated the safety and efficacy of an additional ablative fractional CO2-laser (AFXL) pretreatment. 28 patients with AKs on the head received s-PDT using 5-aminolevulinic acid. AFXL pretreatment was conducted using the following parameters: pulse energy 8 mJ, spot density 50 spots/cm2, power 30 W, beam size 4−18 mm. Outcome was assessed by AK area and severity index (AKASI) and lesion count (LC) before and 3 months after treatment. Safety was monitored by blood pressure and pulse measurements. Intensity of pain was determined by use of a visual analog scale (VAS). Most patients (96.4 %) showed a significant AKASI reduction (P 
ISSN:1572-1000
1873-1597
DOI:10.1016/j.pdpdt.2021.102249